SIGA Technologies Target of Unusually High Options Trading (NASDAQ:SIGA)

SIGA Technologies, Inc. (NASDAQ:SIGAGet Rating) was the recipient of unusually large options trading on Wednesday. Stock investors purchased 1,200 call options on the stock. This is an increase of 1,438% compared to the average volume of 78 call options.

SIGA Technologies Trading Down 3.9 %

Shares of SIGA stock opened at $10.44 on Friday. The stock’s 50-day moving average price is $17.25 and its 200-day moving average price is $11.94. SIGA Technologies has a 12-month low of $5.84 and a 12-month high of $26.99. The stock has a market capitalization of $762.37 million, a price-to-earnings ratio of 10.88 and a beta of 0.67.

SIGA Technologies (NASDAQ:SIGAGet Rating) last released its earnings results on Thursday, August 4th. The company reported $0.03 EPS for the quarter. The firm had revenue of $16.67 million for the quarter. SIGA Technologies had a return on equity of 48.79% and a net margin of 48.67%. As a group, research analysts predict that SIGA Technologies will post 0.66 EPS for the current fiscal year.

Institutional Trading of SIGA Technologies

A number of large investors have recently modified their holdings of the company. UBS Group AG boosted its holdings in shares of SIGA Technologies by 30.3% in the second quarter. UBS Group AG now owns 4,596 shares of the company’s stock valued at $53,000 after purchasing an additional 1,070 shares during the period. Campbell & CO Investment Adviser LLC increased its position in shares of SIGA Technologies by 8.8% during the first quarter. Campbell & CO Investment Adviser LLC now owns 23,399 shares of the company’s stock worth $166,000 after purchasing an additional 1,899 shares in the last quarter. Rhumbline Advisers increased its position in shares of SIGA Technologies by 6.8% during the second quarter. Rhumbline Advisers now owns 55,134 shares of the company’s stock worth $638,000 after purchasing an additional 3,531 shares in the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of SIGA Technologies by 3.1% during the first quarter. Charles Schwab Investment Management Inc. now owns 126,333 shares of the company’s stock worth $896,000 after purchasing an additional 3,804 shares in the last quarter. Finally, Aaron Wealth Advisors LLC acquired a new position in shares of SIGA Technologies in the 1st quarter valued at $548,000. Hedge funds and other institutional investors own 42.55% of the company’s stock.

About SIGA Technologies

(Get Rating)

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats.

Featured Stories

Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.